Lymphoproliferative Disorders

"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Descriptor ID	D008232
MeSH Number(s)	C15.604.515 C20.683.515
Concept/Terms	Lymphoproliferative Disorders Lymphoproliferative Disorders Disorder, Lymphoproliferative Disorders, Lymphoproliferative Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorder Disorder, X-Linked Lymphoproliferative Disorders, X-Linked Lymphoproliferative Lymphoproliferative Disorder, X-Linked Lymphoproliferative Disorders, X-Linked X Linked Lymphoproliferative Disorder X-Linked Lymphoproliferative Disorders Epstein-Barr Virus Infection, Familial Fatal Epstein Barr Virus Infection, Familial Fatal Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males Epstein Barr Virus Induced Lymphoproliferative Disease In Males Familial Fatal Epstein-Barr Infection Familial Fatal Epstein Barr Infection Immunodeficiency 5 Immunodeficiency 5s Duncan's Syndrome Lymphoproliferative Disease, X-Linked Disease, X-Linked Lymphoproliferative Diseases, X-Linked Lymphoproliferative Lymphoproliferative Disease, X Linked Lymphoproliferative Diseases, X-Linked X-Linked Lymphoproliferative Diseases Lymphoproliferative Syndrome, X-Linked, 1 Purtilo Syndrome Purtilo Syndromes Syndrome, Purtilo Syndromes, Purtilo X-Linked Lymphoproliferative Disease X Linked Lymphoproliferative Disease X-Linked Lymphoproliferative Syndrome Lymphoproliferative Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Syndrome, X-Linked Lymphoproliferative Syndromes, X-Linked Lymphoproliferative X Linked Lymphoproliferative Syndrome X-Linked Lymphoproliferative Syndromes Duncan Disease Disease, Duncan Immunodeficiency, X-Linked Progressive Combined Variable Immunodeficiency, X Linked Progressive Combined Variable

Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]

Below are MeSH descriptors whose meaning is related to "Lymphoproliferative Disorders".

Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.

Bar chart showing 19 publications over 13 distinct years, with a maximum of 3 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2003	1	0	1
2004	1	0	1
2005	3	0	3
2006	1	1	2
2009	0	1	1
2010	0	1	1
2011	1	0	1
2012	2	0	2
2013	2	0	2
2015	1	0	1
2016	0	1	1
2022	1	0	1

Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.

Mitsuhashi S, Chalikonda D, Nazir B, Agarwal A, Coben R. Recurrent bleeding duodenal and colonic ulcers due to post-transplant lymphoproliferative disorder. Clin J Gastroenterol. 2023 Feb; 16(1):39-42.

View in: PubMed
Sivak WN, Davidson EH, Komatsu C, Li Y, Miller MR, Schuman JS, Solari MG, Magill G, Washington KM. Ethical Considerations of Whole-Eye Transplantation. J Clin Ethics. 2016; 27(1):64-7.

View in: PubMed
Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA. Human leukocyte antigen type and posttransplant lymphoproliferative disorder. Transplantation. 2015 Jun; 99(6):1220-5.

View in: PubMed
Narkewicz MR, Green M, Dunn S, Millis M, McDiarmid S, Mazariegos G, Anand R, Yin W. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience. Liver Transpl. 2013 Jul; 19(7):730-40.

View in: PubMed
Kutsch E, Kreiger P, Consolini D, Furuya KN. Colonic perforation after rituximab treatment for posttransplant lymphoproliferative disorder. J Pediatr Gastroenterol Nutr. 2013 Jun; 56(6):e41.

View in: PubMed
Marsh RA, Rao K, Satwani P, Lehmberg K, M?ller I, Li D, Kim MO, Fischer A, Latour S, Sedlacek P, Barlogis V, Hamamoto K, Kanegane H, Milanovich S, Margolis DA, Dimmock D, Casper J, Douglas DN, Amrolia PJ, Veys P, Kumar AR, Jordan MB, Bleesing JJ, Filipovich AH. Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes. Blood. 2013 Feb 07; 121(6):877-83.

View in: PubMed
Wang TF, Klein JL, Woodard PK, Hassan A, Joseph SM, Ewald GA, Uy GL. Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literature. J Clin Oncol. 2012 Sep 20; 30(27):e278-82.

View in: PubMed
Nallasamy S, Eagle RC, Rorke-Adams L, Nichols KE, Brucker AJ. Eye findings in X-linked lymphoproliferative disorder. Retina. 2011 Apr; 31(4):790-7.

View in: PubMed
Breitbart SI, Bielory L. Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool. Allergy Asthma Proc. 2010 Sep-Oct; 31(5):428-34.

View in: PubMed
Lin TS, Blum KA, Fischer DB, Mitchell SM, Ruppert AS, Porcu P, Kraut EH, Baiocchi RA, Moran ME, Johnson AJ, Schaaf LJ, Grever MR, Byrd JC. Flavopiridol, fludarabine, and rituximab in mantle cell lymphoma and indolent B-cell lymphoproliferative disorders. J Clin Oncol. 2010 Jan 20; 28(3):418-23.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement